US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TransCode Therapeutics Inc.

2.87

-0.1000-3.37%

Post-market: 3.130.2600+9.06%19:56 EDT

Volume:42.18K

Turnover:124.06K

Market Cap:48.59M

PE:-0.06

High:3.00

Open:2.90

Low:2.87

Close:2.97

52wk High:20.99

52wk Low:2.87

Shares:16.93M

Float Shares:2.07M

Volume Ratio:0.79

T/O Rate:2.03%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-48.7183

EPS(LYR):-52.5900

ROE:-59.28%

ROA:-19.90%

PB:-1.75

PE(LYR):-0.05

Loading ...

Overview Company News Filings

TransCode Therapeutics falls short of Nasdaq $2.5 million stockholders' equity requirement

TransCode Therapeutics Q1 EPS $(21.28) Up From $(70.16) YoY

Benzinga Earnings

TransCode Therapeutics Q1 FY26 net loss widens to $17.79 million

TransCode Therapeutics announces virtual special shareholder meeting

TransCode Registers 1.53 Million Shares for YA II PN Resale Under Equity Purchase Deal

MT Newswires Live

Transcode Therapeutics files to sell 15.96M shares of common stock for holders

Transcode Therapeutics - Files for Resale of up to About 16 Mln Common Shares by Selling Stockholders - SEC Filing

THOMSON REUTERS

Transcode Therapeutics Appoints DR. Anna Moore as Chair of Scientific Advisory Board; Announces Sponsored Research Agreement With Michigan State University

THOMSON REUTERS

Press Release: TransCode Therapeutics Appoints Dr. Anna Moore as Chair of Scientific Advisory Board; Announces Sponsored Research Agreement with Michigan State University

CK Life Sciences publishes 2025 annual report

TransCode Therapeutics FY25 net loss widens to $34.7 million

Transcode Therapeutics signs flexible financing agreement for up to $20M

TransCode Therapeutics Secures New Financing to Extend Runway

Press Release: TransCode Therapeutics Enters into Agreements for up to $20 Million Flexible Financing, Extending Company's Runway into Late 2027/Early 2028

TransCode Therapeutics Delays 2025 Annual Filing

TransCode Therapeutics delays annual report filing, cites complex accounting for transactions

TransCode Therapeutics Issues 1.14M Non-Voting Convertible Preferred Shares in Private Placement

TransCode Therapeutics Expands Pipeline With Oncolytic Virus Deal

Transcode Therapeutics enters exclusive license agreement with Unleash

BRIEF-Transcode Therapeutics Inc - Enters Exclusive License Agreement With Unleash

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/RNAZ/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RNAZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNAZ\",,,,,undefined,":{"symbol":"RNAZ","market":"US","secType":"STK","nameCN":"TransCode Therapeutics  Inc.","latestPrice":2.87,"timestamp":1787342400000,"preClose":2.97,"halted":0,"volume":42178,"hourTrading":{"tag":"盘后","latestPrice":3.13,"preClose":2.87,"latestTime":"19:56 EDT","volume":3818,"amount":11628.4333,"timestamp":1787356581455,"change":0.26,"changeRate":0.090592,"amplitude":0.048118},"delay":0,"changeRate":-0.0336700336700337,"floatShares":2074199,"shares":16930739,"eps":-48.7183,"marketStatus":"Market Closed","change":-0.1,"latestTime":"08-21 16:00:00 EDT","open":2.9,"high":3,"low":2.87,"amount":124058.8810794,"amplitude":0.043771,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-48.7183,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1622520000000,"exchange":"NASDAQ","adjPreClose":2.97,"preHourTrading":{"tag":"盘前","latestPrice":3.14,"preClose":2.97,"latestTime":"08:36 EDT","volume":227,"amount":705.0800011,"timestamp":1787315763249,"change":0.17,"changeRate":0.057239,"amplitude":0.074074},"postHourTrading":{"tag":"盘后","latestPrice":3.13,"preClose":2.87,"latestTime":"19:56 EDT","volume":3818,"amount":11628.4333,"timestamp":1787356581455,"change":0.26,"changeRate":0.090592,"amplitude":0.048118},"volumeRatio":0.7923786756326796},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNAZ\",,,,,undefined,":{"symbol":"RNAZ","floatShares":2074199,"roa":"-19.90%","roe":"-59.28%","lyrEps":-52.59,"volumeRatio":0.7923786756326796,"shares":16930739,"dividePrice":0,"high":3,"amplitude":0.043771,"preClose":2.97,"low":2.87,"week52Low":2.87,"pbRate":"-1.75","week52High":20.99,"institutionHeld":0,"latestPrice":2.87,"eps":-48.7183,"divideRate":0,"volume":42178,"delay":0,"ttmEps":-48.7183,"open":2.9,"prevYearClose":6.83,"prevWeekClose":3.28,"prevMonthClose":4.56,"prevQuarterClose":6.21,"fiveDayClose":3.28,"twentyDayClose":5.93,"sixtyDayClose":5.09},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RNAZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-15","symbol":"RNAZ","defaultRemindTime":1747315800000,"type":"split","dateTimestamp":1747281600000,"forFactor":28,"toFactor":1,"ratio":28},{"market":"US","date":"2024-12-04","symbol":"RNAZ","defaultRemindTime":1733322600000,"type":"split","dateTimestamp":1733288400000,"forFactor":33,"toFactor":1,"ratio":33},{"market":"US","date":"2024-01-16","symbol":"RNAZ","defaultRemindTime":1705415400000,"type":"split","dateTimestamp":1705381200000,"forFactor":40,"toFactor":1,"ratio":40},{"market":"US","date":"2023-05-23","symbol":"RNAZ","defaultRemindTime":1684848600000,"type":"split","dateTimestamp":1684814400000,"forFactor":20,"toFactor":1,"ratio":20},{"market":"US","date":"2021-08-23","symbol":"RNAZ","fiscalQuarterEnding":"2021/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1629691200000,"reportTimeType":"","actualEps":0.51}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RNAZ\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RNAZ\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RNAZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RNAZ","date":"2026-08-21","current":-0.05891,"percent":0.966503,"low":-13.297156,"twenty":-2.685345,"median":-0.348734,"eighty":-0.220957,"high":-0.024019,"avg":-1.55601,"sd":2.639892,"marketCap":3143688},"quantilePoints":[{"date":"2021-08-27","current":-10.254026,"twenty":-14.365299,"median":-5.811369,"eighty":-5.083853,"marketCap":39886816},{"date":"2021-09-03","current":-8.929933,"twenty":-11.30719,"median":-6.205807,"eighty":-5.09963,"marketCap":34736270},{"date":"2021-09-10","current":-9.261701,"twenty":-10.464659,"median":-7.012211,"eighty":-5.101032,"marketCap":36026802},{"date":"2021-09-17","current":-8.037833,"twenty":-10.121716,"median":-7.012211,"eighty":-5.129432,"marketCap":31266117},{"date":"2021-09-24","current":-12.106366,"twenty":-10.464659,"median":-7.99392,"eighty":-5.178518,"marketCap":47092176},{"date":"2021-10-01","current":-9.460165,"twenty":-10.702816,"median":-8.236298,"eighty":-5.217085,"marketCap":36798804},{"date":"2021-10-08","current":-9.096313,"twenty":-10.445875,"median":-8.533995,"eighty":-5.308243,"marketCap":35383466},{"date":"2021-10-15","current":-10.650956,"twenty":-10.598032,"median":-8.782076,"eighty":-5.399402,"marketCap":41430822},{"date":"2021-10-22","current":-9.096313,"twenty":-10.598032,"median":-9.096313,"eighty":-5.459006,"marketCap":35383466},{"date":"2021-10-29","current":-9.360933,"twenty":-10.558339,"median":-9.12939,"eighty":-5.483549,"marketCap":36412803},{"date":"2021-11-05","current":-10.849421,"twenty":-10.750188,"median":-9.228623,"eighty":-5.543153,"marketCap":42202825},{"date":"2021-11-12","current":-9.757863,"twenty":-10.750188,"median":-9.261701,"eighty":-5.557177,"marketCap":37956809},{"date":"2021-11-19","current":-7.259636,"twenty":-10.670802,"median":-9.228623,"eighty":-5.571202,"marketCap":35177810},{"date":"2021-11-26","current":-7.153268,"twenty":-10.611263,"median":-9.162468,"eighty":-5.616781,"marketCap":34662385},{"date":"2021-12-03","current":-7.17986,"twenty":-10.564954,"median":-9.096313,"eighty":-5.686903,"marketCap":34791241},{"date":"2021-12-10","current":-7.153268,"twenty":-10.472337,"median":-8.831693,"eighty":-5.735989,"marketCap":34662385},{"date":"2021-12-17","current":-6.860756,"twenty":-10.419413,"median":-8.60015,"eighty":-5.781568,"marketCap":33244964},{"date":"2021-12-23","current":-7.126676,"twenty":-10.353258,"median":-8.451301,"eighty":-5.809616,"marketCap":34533528},{"date":"2021-12-31","current":-6.754387,"twenty":-10.227564,"median":-8.037833,"eighty":-5.869221,"marketCap":32729538},{"date":"2022-01-07","current":-6.461874,"twenty":-10.148178,"median":-7.959179,"eighty":-6.048032,"marketCap":31312117},{"date":"2022-01-14","current":-6.674611,"twenty":-10.075407,"median":-7.764886,"eighty":-6.28696,"marketCap":32342968},{"date":"2022-01-21","current":-5.398191,"twenty":-10.035714,"median":-7.658518,"eighty":-5.961559,"marketCap":26157859},{"date":"2022-01-28","current":-6.036401,"twenty":-9.943097,"median":-7.405893,"eighty":-5.890049,"marketCap":29250414},{"date":"2022-02-04","current":-6.435282,"twenty":-9.890173,"median":-7.259636,"eighty":-5.961559,"marketCap":31183260},{"date":"2022-02-11","current":-5.517856,"twenty":-9.883557,"median":-7.233044,"eighty":-5.961559,"marketCap":26737713},{"date":"2022-02-18","current":-5.850257,"twenty":-9.85048,"median":-7.17986,"eighty":-5.855575,"marketCap":28348419},{"date":"2022-02-25","current":-5.797072,"twenty":-9.824018,"median":-7.17986,"eighty":-5.802604,"marketCap":28090706},{"date":"2022-03-04","current":-5.956625,"twenty":-9.824018,"median":-7.139972,"eighty":-5.750013,"marketCap":28863844},{"date":"2022-03-11","current":-6.328914,"twenty":-9.757863,"median":-7.012211,"eighty":-5.750013,"marketCap":30667835},{"date":"2022-03-18","current":-6.780979,"twenty":-9.757863,"median":-7.012211,"eighty":-5.743888,"marketCap":32858394},{"date":"2022-03-25","current":-6.54165,"twenty":-9.757863,"median":-6.91394,"eighty":-5.750013,"marketCap":31698686},{"date":"2022-04-01","current":-5.336521,"twenty":-9.757863,"median":-6.953828,"eighty":-5.743888,"marketCap":36519944},{"date":"2022-04-08","current":-5.713661,"twenty":-9.757863,"median":-6.91394,"eighty":-5.690704,"marketCap":39100859},{"date":"2022-04-14","current":-5.406292,"twenty":-9.757863,"median":-6.887347,"eighty":-5.660256,"marketCap":36997413},{"date":"2022-04-22","current":-5.072524,"twenty":-9.704939,"median":-6.840812,"eighty":-5.571315,"marketCap":34713304},{"date":"2022-04-29","current":-5.147952,"twenty":-9.58586,"median":-6.780979,"eighty":-5.549313,"marketCap":35229487},{"date":"2022-05-06","current":-5.214864,"twenty":-9.480012,"median":-6.767683,"eighty":-5.483549,"marketCap":35687393},{"date":"2022-05-13","current":-4.266707,"twenty":-9.460165,"median":-6.754387,"eighty":-5.429601,"marketCap":29198776},{"date":"2022-05-20","current":-4.475575,"twenty":-9.407241,"median":-6.674611,"eighty":-5.404672,"marketCap":26084240},{"date":"2022-05-27","current":-4.074778,"twenty":-9.39401,"median":-6.674611,"eighty":-5.336521,"marketCap":23748338},{"date":"2022-06-03","current":-3.941178,"twenty":-9.374164,"median":-6.621427,"eighty":-5.324634,"marketCap":22969704},{"date":"2022-06-10","current":-3.629447,"twenty":-9.360933,"median":-6.54165,"eighty":-5.272407,"marketCap":21152891},{"date":"2022-06-17","current":-2.671985,"twenty":-9.308563,"median":-6.488466,"eighty":-5.22381,"marketCap":15572680},{"date":"2022-06-24","current":-2.850118,"twenty":-9.26887,"median":-6.461874,"eighty":-5.199367,"marketCap":16610859},{"date":"2022-07-01","current":-2.761052,"twenty":-9.261701,"median":-6.435282,"eighty":-5.137471,"marketCap":16091770},{"date":"2022-07-08","current":-3.094827,"twenty":-9.261701,"median":-6.40869,"eighty":-5.087008,"marketCap":18037057},{"date":"2022-07-15","current":-2.939184,"twenty":-9.261701,"median":-6.328914,"eighty":-4.996097,"marketCap":17129948},{"date":"2022-07-22","current":-2.872384,"twenty":-9.255085,"median":-6.227473,"eighty":-4.960352,"marketCap":16740631},{"date":"2022-07-29","current":-3.161849,"twenty":-9.222007,"median":-6.116177,"eighty":-4.771809,"marketCap":18427672},{"date":"2022-08-05","current":-3.195249,"twenty":-9.18893,"median":-6.116177,"eighty":-4.618082,"marketCap":18622330},{"date":"2022-08-12","current":-2.872384,"twenty":-9.149237,"median":-6.036401,"eighty":-4.456649,"marketCap":16740631},{"date":"2022-08-19","current":-1.241956,"twenty":-9.096313,"median":-6.023105,"eighty":-4.180624,"marketCap":16481087},{"date":"2022-08-26","current":-1.095268,"twenty":-9.096313,"median":-5.942849,"eighty":-4.079231,"marketCap":14534502},{"date":"2022-09-02","current":-1.163722,"twenty":-9.063037,"median":-5.890145,"eighty":-3.972352,"marketCap":15442908},{"date":"2022-09-09","current":-1.105047,"twenty":-8.929933,"median":-5.850257,"eighty":-3.629447,"marketCap":14664274},{"date":"2022-09-16","current":-1.085489,"twenty":-8.831693,"median":-5.802604,"eighty":-3.228649,"marketCap":14404729},{"date":"2022-09-23","current":-1.007256,"twenty":-8.73246,"median":-5.773542,"eighty":-3.161849,"marketCap":13366551},{"date":"2022-09-30","current":-1.07571,"twenty":-8.666305,"median":-5.743888,"eighty":-3.094827,"marketCap":14274957},{"date":"2022-10-07","current":-1.19306,"twenty":-8.533995,"median":-5.702183,"eighty":-3.02825,"marketCap":15832225},{"date":"2022-10-14","current":-1.086467,"twenty":-8.533995,"median":-5.675947,"eighty":-2.983717,"marketCap":14417706},{"date":"2022-10-21","current":-1.065931,"twenty":-8.368608,"median":-5.641175,"eighty":-2.939184,"marketCap":14145185},{"date":"2022-10-28","current":-0.745956,"twenty":-8.103988,"median":-5.574708,"eighty":-2.894651,"marketCap":9899034},{"date":"2022-11-04","current":-0.567192,"twenty":-8.037833,"median":-5.55746,"eighty":-2.872384,"marketCap":7526795},{"date":"2022-11-11","current":-0.513407,"twenty":-8.004215,"median":-5.517856,"eighty":-2.827851,"marketCap":6813047},{"date":"2022-11-18","current":-0.451599,"twenty":-7.99392,"median":-5.495807,"eighty":-2.761052,"marketCap":6877934},{"date":"2022-11-25","current":-0.416494,"twenty":-7.938335,"median":-5.469022,"eighty":-2.688237,"marketCap":6343271},{"date":"2022-12-02","current":-0.366392,"twenty":-7.856382,"median":-5.430806,"eighty":-1.257602,"marketCap":5580210},{"date":"2022-12-09","current":-0.458075,"twenty":-7.779782,"median":-5.420196,"eighty":-1.200883,"marketCap":6976560},{"date":"2022-12-16","current":-0.366392,"twenty":-7.743612,"median":-5.398191,"eighty":-1.173502,"marketCap":5580210},{"date":"2022-12-23","current":-0.30794,"twenty":-7.674473,"median":-5.355378,"eighty":-1.163722,"marketCap":4689972},{"date":"2022-12-30","current":-0.573446,"twenty":-7.610652,"median":-5.336521,"eighty":-1.150031,"marketCap":8733678},{"date":"2023-01-06","current":-0.540811,"twenty":-7.546831,"median":-5.323472,"eighty":-1.138297,"marketCap":8236650},{"date":"2023-01-13","current":-0.521469,"twenty":-7.477691,"median":-5.27995,"eighty":-1.124606,"marketCap":7942067},{"date":"2023-01-20","current":-0.582393,"twenty":-7.419189,"median":-5.261093,"eighty":-1.107003,"marketCap":8869939},{"date":"2023-01-27","current":-0.651837,"twenty":-7.312821,"median":-5.242595,"eighty":-1.095268,"marketCap":9927584},{"date":"2023-02-03","current":-0.533484,"twenty":-7.302184,"median":-5.214864,"eighty":-1.095268,"marketCap":8125046},{"date":"2023-02-10","current":-0.413256,"twenty":-7.259636,"median":-5.168494,"eighty":-1.077744,"marketCap":6293958},{"date":"2023-02-17","current":-0.545246,"twenty":-7.259636,"median":-5.139011,"eighty":-1.058107,"marketCap":8304190},{"date":"2023-02-24","current":-0.446753,"twenty":-7.259636,"median":-5.101383,"eighty":-1.017035,"marketCap":6804119},{"date":"2023-03-03","current":-0.477921,"twenty":-7.259636,"median":-5.078188,"eighty":-0.987697,"marketCap":7278825},{"date":"2023-03-10","current":-0.414545,"twenty":-7.259636,"median":-5.031261,"eighty":-0.742156,"marketCap":6313590},{"date":"2023-03-17","current":-0.336207,"twenty":-7.206452,"median":-4.969511,"eighty":-0.639737,"marketCap":5120495},{"date":"2023-03-24","current":-0.331428,"twenty":-7.206452,"median":-4.960352,"eighty":-0.630535,"marketCap":5047707},{"date":"2023-03-31","current":-0.351688,"twenty":-7.17986,"median":-4.820895,"eighty":-0.589635,"marketCap":5356266},{"date":"2023-04-06","current":-0.45174,"twenty":-7.17986,"median":-4.766672,"eighty":-0.576377,"marketCap":6880072},{"date":"2023-04-14","current":-0.359623,"twenty":-7.17986,"median":-4.653708,"eighty":-0.562385,"marketCap":6316770},{"date":"2023-04-21","current":-0.3153,"twenty":-7.158586,"median":-4.508975,"eighty":-0.54538,"marketCap":5538236},{"date":"2023-04-28","current":-0.301157,"twenty":-7.153268,"median":-4.453309,"eighty":-0.536142,"marketCap":5289807},{"date":"2023-05-05","current":-0.280887,"twenty":-7.131994,"median":-4.257226,"eighty":-0.526923,"marketCap":4933777},{"date":"2023-05-12","current":-0.26233,"twenty":-7.07881,"median":-4.141578,"eighty":-0.517222,"marketCap":4607813},{"date":"2023-05-19","current":-0.244735,"twenty":-7.033024,"median":-4.108178,"eighty":-0.502627,"marketCap":4628383},{"date":"2023-05-26","current":-0.218865,"twenty":-7.012211,"median":-4.052511,"eighty":-0.493236,"marketCap":4139139},{"date":"2023-06-02","current":-0.177519,"twenty":-7.012211,"median":-4.007978,"eighty":-0.484966,"marketCap":3357207},{"date":"2023-06-09","current":-0.429482,"twenty":-7.012211,"median":-3.952311,"eighty":-0.474116,"marketCap":8122289},{"date":"2023-06-16","current":-0.396344,"twenty":-7.012211,"median":-3.629447,"eighty":-0.464845,"marketCap":7495590},{"date":"2023-06-23","current":-0.238101,"twenty":-7.001114,"median":-3.339982,"eighty":-0.453859,"marketCap":4502917},{"date":"2023-06-30","current":-0.230481,"twenty":-6.961806,"median":-3.228649,"eighty":-0.448691,"marketCap":4358824},{"date":"2023-07-07","current":-0.2181,"twenty":-6.91394,"median":-3.195249,"eighty":-0.438648,"marketCap":4124672},{"date":"2023-07-13","current":-0.26953,"twenty":-6.91394,"median":-3.161849,"eighty":-0.429701,"marketCap":5097302},{"date":"2023-07-21","current":-0.235243,"twenty":-6.91394,"median":-3.106183,"eighty":-0.417426,"marketCap":4448882},{"date":"2023-07-28","current":-0.225719,"twenty":-6.91394,"median":-3.072783,"eighty":-0.413256,"marketCap":4268765},{"date":"2023-08-04","current":-0.17429,"twenty":-6.887347,"median":-3.050516,"eighty":-0.400475,"marketCap":3296135},{"date":"2023-08-11","current":-0.160004,"twenty":-6.887347,"median":-3.02825,"eighty":-0.38961,"marketCap":3025960},{"date":"2023-08-18","current":-0.157995,"twenty":-6.860756,"median":-2.972583,"eighty":-0.383263,"marketCap":2935902},{"date":"2023-08-25","current":-0.188589,"twenty":-6.820867,"median":-2.96145,"eighty":-0.363636,"marketCap":3504416},{"date":"2023-09-01","current":-0.158066,"twenty":-6.780979,"median":-2.939184,"eighty":-0.359623,"marketCap":2937227},{"date":"2023-09-08","current":-0.125363,"twenty":-6.780979,"median":-2.905784,"eighty":-0.354845,"marketCap":2329525},{"date":"2023-09-15","current":-0.080668,"twenty":-6.780979,"median":-2.872384,"eighty":-0.351688,"marketCap":1498998},{"date":"2023-09-22","current":-0.07597,"twenty":-6.780979,"median":-2.870157,"eighty":-0.348588,"marketCap":1411692},{"date":"2023-09-29","current":-0.062714,"twenty":-6.759705,"median":-2.827851,"eighty":-0.342044,"marketCap":1165370},{"date":"2023-10-06","current":-0.071025,"twenty":-6.754387,"median":-2.816718,"eighty":-0.335629,"marketCap":1319806},{"date":"2023-10-13","current":-0.069464,"twenty":-6.754387,"median":-2.761052,"eighty":-0.331116,"marketCap":1290799},{"date":"2023-10-20","current":-0.062018,"twenty":-6.722231,"median":-2.715542,"eighty":-0.328027,"marketCap":1152437},{"date":"2023-10-27","current":-0.064937,"twenty":-6.706276,"median":-2.682142,"eighty":-0.320027,"marketCap":1206680},{"date":"2023-11-03","current":-0.394873,"twenty":-6.674611,"median":-1.281073,"eighty":-0.325669,"marketCap":7337632},{"date":"2023-11-10","current":-0.374108,"twenty":-6.674611,"median":-1.222398,"eighty":-0.328975,"marketCap":6951778},{"date":"2023-11-17","current":-0.266701,"twenty":-6.674611,"median":-1.202839,"eighty":-0.325669,"marketCap":5225374},{"date":"2023-11-24","current":-0.246083,"twenty":-6.674611,"median":-1.19306,"eighty":-0.313052,"marketCap":4821413},{"date":"2023-12-01","current":-0.252341,"twenty":-6.648019,"median":-1.173502,"eighty":-0.301157,"marketCap":4944008},{"date":"2023-12-08","current":-0.257476,"twenty":-6.621427,"median":-1.163722,"eighty":-0.294624,"marketCap":5044616},{"date":"2023-12-15","current":-0.216613,"twenty":-6.594835,"median":-1.158832,"eighty":-0.284581,"marketCap":4244003},{"date":"2023-12-22","current":-0.21277,"twenty":-6.54165,"median":-1.144164,"eighty":-0.278188,"marketCap":4168710},{"date":"2023-12-29","current":-0.219174,"twenty":-6.54165,"median":-1.144164,"eighty":-0.276419,"marketCap":4294198},{"date":"2024-01-05","current":-0.187022,"twenty":-6.536278,"median":-1.134385,"eighty":-0.272473,"marketCap":3664249},{"date":"2024-01-12","current":-0.174212,"twenty":-6.509527,"median":-1.129495,"eighty":-0.267111,"marketCap":3413273},{"date":"2024-01-19","current":-0.034907,"twenty":-6.488466,"median":-1.124606,"eighty":-0.258101,"marketCap":683918},{"date":"2024-01-26","current":-0.245163,"twenty":-6.461874,"median":-1.105047,"eighty":-0.25511,"marketCap":4803378},{"date":"2024-02-02","current":-0.228731,"twenty":-6.461874,"median":-1.100157,"eighty":-0.252387,"marketCap":4481445},{"date":"2024-02-09","current":-0.226015,"twenty":-6.435282,"median":-1.095268,"eighty":-0.249824,"marketCap":4428227},{"date":"2024-02-16","current":-0.222025,"twenty":-6.435282,"median":-1.095268,"eighty":-0.245163,"marketCap":4350044},{"date":"2024-02-23","current":-0.243453,"twenty":-6.435282,"median":-1.085978,"eighty":-0.244479,"marketCap":4769871},{"date":"2024-03-01","current":-0.236277,"twenty":-6.414008,"median":-1.075808,"eighty":-0.242065,"marketCap":4629272},{"date":"2024-03-08","current":-0.244794,"twenty":-6.40869,"median":-1.07082,"eighty":-0.241215,"marketCap":4796151},{"date":"2024-03-15","current":-0.231347,"twenty":-6.37678,"median":-1.054196,"eighty":-0.238072,"marketCap":4532691},{"date":"2024-03-22","current":-0.228698,"twenty":-6.336892,"median":-1.014394,"eighty":-0.236326,"marketCap":4480788},{"date":"2024-03-28","current":-0.227658,"twenty":-6.312959,"median":-1.007207,"eighty":-0.235241,"marketCap":4460421},{"date":"2024-04-05","current":-0.240859,"twenty":-6.270412,"median":-0.835033,"eighty":-0.235103,"marketCap":4466991},{"date":"2024-04-12","current":-0.200193,"twenty":-6.223139,"median":-0.744056,"eighty":-0.234734,"marketCap":3712797},{"date":"2024-04-19","current":-0.157211,"twenty":-6.152029,"median":-0.657161,"eighty":-0.233326,"marketCap":2915642},{"date":"2024-04-26","current":-0.164413,"twenty":-6.116177,"median":-0.637734,"eighty":-0.231025,"marketCap":3049227},{"date":"2024-05-03","current":-0.232846,"twenty":-6.116177,"median":-0.632224,"eighty":-0.230356,"marketCap":4318393},{"date":"2024-05-10","current":-0.438028,"twenty":-6.116177,"median":-0.613536,"eighty":-0.230455,"marketCap":8123710},{"date":"2024-05-17","current":-0.316863,"twenty":-6.116177,"median":-0.589635,"eighty":-0.230455,"marketCap":5404405},{"date":"2024-05-24","current":-0.539673,"twenty":-6.100222,"median":-0.579751,"eighty":-0.230518,"marketCap":9204653},{"date":"2024-05-31","current":-0.636737,"twenty":-6.068311,"median":-0.584621,"eighty":-0.230864,"marketCap":10860166},{"date":"2024-06-07","current":-0.520261,"twenty":-6.036401,"median":-0.582393,"eighty":-0.231361,"marketCap":8873551},{"date":"2024-06-14","current":-0.45814,"twenty":-6.036401,"median":-0.573446,"eighty":-0.231448,"marketCap":7814022},{"date":"2024-06-21","current":-0.396019,"twenty":-6.036401,"median":-0.567192,"eighty":-0.231716,"marketCap":6754494},{"date":"2024-06-28","current":-0.392137,"twenty":-6.025764,"median":-0.562969,"eighty":-0.231716,"marketCap":6688273},{"date":"2024-07-05","current":-0.337043,"twenty":-5.999172,"median":-0.562107,"eighty":-0.231942,"marketCap":5748604},{"date":"2024-07-12","current":-0.37061,"twenty":-5.95387,"median":-0.549375,"eighty":-0.233157,"marketCap":6321122},{"date":"2024-07-15","current":-0.365073,"twenty":-5.951115,"median":-0.545413,"eighty":-0.233467,"marketCap":6226668},{"date":"2024-08-02","current":-0.279596,"twenty":-5.948359,"median":-0.54533,"eighty":-0.233778,"marketCap":4768774},{"date":"2024-08-09","current":-0.261577,"twenty":-5.935159,"median":-0.540811,"eighty":-0.23458,"marketCap":4461446},{"date":"2024-08-16","current":-0.241071,"twenty":-5.914078,"median":-0.535146,"eighty":-0.23458,"marketCap":4316414},{"date":"2024-08-23","current":-0.268168,"twenty":-5.887486,"median":-0.528286,"eighty":-0.2347,"marketCap":4801579},{"date":"2024-08-30","current":-0.268843,"twenty":-5.860894,"median":-0.524747,"eighty":-0.23472,"marketCap":4813665},{"date":"2024-09-06","current":-0.265178,"twenty":-5.850257,"median":-0.520013,"eighty":-0.2347,"marketCap":4748055},{"date":"2024-09-13","current":-0.243964,"twenty":-5.838208,"median":-0.51569,"eighty":-0.234714,"marketCap":4368211},{"date":"2024-09-20","current":-0.3645,"twenty":-5.813123,"median":-0.509454,"eighty":-0.234734,"marketCap":6526418},{"date":"2024-09-27","current":-0.593228,"twenty":-5.800391,"median":-0.508517,"eighty":-0.234734,"marketCap":10621832},{"date":"2024-10-04","current":-0.591107,"twenty":-5.797072,"median":-0.509454,"eighty":-0.234734,"marketCap":10583848},{"date":"2024-10-11","current":-0.70335,"twenty":-5.778248,"median":-0.513407,"eighty":-0.234801,"marketCap":12593570},{"date":"2024-10-18","current":-0.577607,"twenty":-5.747563,"median":-0.519765,"eighty":-0.235036,"marketCap":10342129},{"date":"2024-10-25","current":-0.6264,"twenty":-5.743888,"median":-0.521196,"eighty":-0.235239,"marketCap":11215771},{"date":"2024-10-31","current":-0.486,"twenty":-5.738101,"median":-0.521469,"eighty":-0.235434,"marketCap":8701891},{"date":"2024-11-08","current":-0.453214,"twenty":-5.714694,"median":-0.520013,"eighty":-0.236212,"marketCap":8114859},{"date":"2024-11-15","current":-0.337403,"twenty":-5.70907,"median":-0.51569,"eighty":-0.236289,"marketCap":6041253},{"date":"2024-11-22","current":-0.439549,"twenty":-5.690704,"median":-0.509454,"eighty":-0.236554,"marketCap":6560950},{"date":"2024-11-29","current":-0.402534,"twenty":-5.690704,"median":-0.499775,"eighty":-0.237417,"marketCap":6008448},{"date":"2024-12-06","current":-0.30495,"twenty":-5.675947,"median":-0.496415,"eighty":-0.237718,"marketCap":4551848},{"date":"2024-12-13","current":-0.252723,"twenty":-5.664112,"median":-0.493246,"eighty":-0.237958,"marketCap":3772279},{"date":"2024-12-20","current":-0.134949,"twenty":-5.64483,"median":-0.486,"eighty":-0.236338,"marketCap":2014323},{"date":"2024-12-27","current":-0.136351,"twenty":-5.638982,"median":-0.481763,"eighty":-0.235767,"marketCap":2035251},{"date":"2025-01-03","current":-0.123732,"twenty":-5.621565,"median":-0.477921,"eighty":-0.234835,"marketCap":1846899},{"date":"2025-01-10","current":-0.120227,"twenty":-5.59644,"median":-0.477553,"eighty":-0.234734,"marketCap":1794579},{"date":"2025-01-17","current":-0.117423,"twenty":-5.567922,"median":-0.472095,"eighty":-0.233467,"marketCap":1752723},{"date":"2025-01-24","current":-0.192784,"twenty":-5.557744,"median":-0.467653,"eighty":-0.231448,"marketCap":2877605},{"date":"2025-01-31","current":-0.375492,"twenty":-5.557631,"median":-0.466511,"eighty":-0.231716,"marketCap":5604804},{"date":"2025-02-07","current":-0.530353,"twenty":-5.557177,"median":-0.46549,"eighty":-0.231942,"marketCap":7916351},{"date":"2025-02-14","current":-0.497235,"twenty":-5.549313,"median":-0.466511,"eighty":-0.233157,"marketCap":7422014},{"date":"2025-02-21","current":-0.437063,"twenty":-5.517856,"median":-0.466511,"eighty":-0.234399,"marketCap":6523853},{"date":"2025-02-28","current":-0.117545,"twenty":-5.50456,"median":-0.464726,"eighty":-0.231716,"marketCap":1754547},{"date":"2025-03-07","current":-0.07883,"twenty":-5.50456,"median":-0.459919,"eighty":-0.230702,"marketCap":1176660},{"date":"2025-03-14","current":-0.034611,"twenty":-5.487055,"median":-0.45816,"eighty":-0.230267,"marketCap":516616},{"date":"2025-03-21","current":-0.035917,"twenty":-5.469524,"median":-0.455272,"eighty":-0.228053,"marketCap":536111},{"date":"2025-03-28","current":-0.813147,"twenty":-5.46852,"median":-0.454243,"eighty":-0.227692,"marketCap":12137494},{"date":"2025-04-04","current":-0.722763,"twenty":-5.46852,"median":-0.45814,"eighty":-0.227692,"marketCap":10788365},{"date":"2025-04-11","current":-0.623309,"twenty":-5.430806,"median":-0.459919,"eighty":-0.228053,"marketCap":9303856},{"date":"2025-04-17","current":-0.496779,"twenty":-5.425988,"median":-0.463616,"eighty":-0.228569,"marketCap":8323520},{"date":"2025-04-25","current":-0.55724,"twenty":-5.423723,"median":-0.459919,"eighty":-0.228724,"marketCap":9336534},{"date":"2025-05-02","current":-0.785708,"twenty":-5.418238,"median":-0.464726,"eighty":-0.228973,"marketCap":13164513},{"date":"2025-05-09","current":-0.487863,"twenty":-5.40842,"median":-0.466511,"eighty":-0.23002,"marketCap":8174135},{"date":"2025-05-16","current":-0.249953,"twenty":-5.399811,"median":-0.467234,"eighty":-0.230385,"marketCap":6377185},{"date":"2025-05-23","current":-0.248972,"twenty":-5.388064,"median":-0.465905,"eighty":-0.230022,"marketCap":6352176},{"date":"2025-05-30","current":-0.225447,"twenty":-5.378754,"median":-0.464376,"eighty":-0.228718,"marketCap":5751971},{"date":"2025-06-06","current":-0.235903,"twenty":-5.351607,"median":-0.459919,"eighty":-0.228718,"marketCap":6018729},{"date":"2025-06-13","current":-0.235413,"twenty":-5.336521,"median":-0.45814,"eighty":-0.228912,"marketCap":6006224},{"date":"2025-06-20","current":-0.228061,"twenty":-5.336521,"median":-0.455272,"eighty":-0.228316,"marketCap":5818660},{"date":"2025-06-27","current":-0.26825,"twenty":-5.333625,"median":-0.451995,"eighty":-0.228711,"marketCap":6844011},{"date":"2025-07-03","current":-0.276091,"twenty":-5.326957,"median":-0.451599,"eighty":-0.228791,"marketCap":7044080},{"date":"2025-07-11","current":-0.294062,"twenty":-5.313893,"median":-0.446753,"eighty":-0.229035,"marketCap":7502571},{"date":"2025-07-18","current":-0.328369,"twenty":-5.295036,"median":-0.443773,"eighty":-0.22914,"marketCap":8377870},{"date":"2025-07-25","current":-0.359437,"twenty":-5.27995,"median":-0.438727,"eighty":-0.229679,"marketCap":9170513},{"date":"2025-08-01","current":-0.362704,"twenty":-5.276179,"median":-0.438196,"eighty":-0.230297,"marketCap":9253881},{"date":"2025-08-08","current":-0.348,"twenty":-5.261093,"median":-0.437433,"eighty":-0.230428,"marketCap":8878723},{"date":"2025-08-15","current":-0.36107,"twenty":-5.261093,"median":-0.435462,"eighty":-0.230493,"marketCap":9212197},{"date":"2025-08-22","current":-0.319249,"twenty":-5.253694,"median":-0.433115,"eighty":-0.230574,"marketCap":7853293},{"date":"2025-08-29","current":-0.334839,"twenty":-5.223953,"median":-0.429592,"eighty":-0.230831,"marketCap":8236788},{"date":"2025-09-05","current":-0.355851,"twenty":-5.223379,"median":-0.426621,"eighty":-0.231347,"marketCap":8753671},{"date":"2025-09-12","current":-0.379574,"twenty":-5.214864,"median":-0.418933,"eighty":-0.231381,"marketCap":9337249},{"date":"2025-09-19","current":-0.380591,"twenty":-5.214864,"median":-0.417216,"eighty":-0.231655,"marketCap":9362260},{"date":"2025-09-26","current":-0.336194,"twenty":-5.189036,"median":-0.415471,"eighty":-0.231716,"marketCap":8270135},{"date":"2025-10-03","current":-0.358562,"twenty":-5.147952,"median":-0.413901,"eighty":-0.231716,"marketCap":8820366},{"date":"2025-10-10","current":-0.500903,"twenty":-5.147952,"median":-0.414143,"eighty":-0.232846,"marketCap":12321834},{"date":"2025-10-17","current":-0.505647,"twenty":-5.139011,"median":-0.415392,"eighty":-0.233289,"marketCap":12438550},{"date":"2025-10-24","current":-0.445322,"twenty":-5.136444,"median":-0.417006,"eighty":-0.234399,"marketCap":10954594},{"date":"2025-10-31","current":-0.371102,"twenty":-5.101383,"median":-0.417216,"eighty":-0.2347,"marketCap":9128828},{"date":"2025-11-07","current":-0.314843,"twenty":-5.09963,"median":-0.415471,"eighty":-0.2347,"marketCap":7744915},{"date":"2025-11-14","current":-0.285359,"twenty":-5.083853,"median":-0.414344,"eighty":-0.234734,"marketCap":7019610},{"date":"2025-11-21","current":-0.263004,"twenty":-5.072524,"median":-0.413256,"eighty":-0.234734,"marketCap":7136326},{"date":"2025-11-28","current":-0.313948,"twenty":-5.067562,"median":-0.411836,"eighty":-0.234734,"marketCap":8518632},{"date":"2025-12-05","current":-0.291836,"twenty":-5.038273,"median":-0.403424,"eighty":-0.234734,"marketCap":7918660},{"date":"2025-12-12","current":-0.352135,"twenty":-4.996097,"median":-0.40212,"eighty":-0.234868,"marketCap":9554806},{"date":"2025-12-19","current":-0.265284,"twenty":-4.980397,"median":-0.400432,"eighty":-0.23517,"marketCap":7198198},{"date":"2025-12-26","current":-0.251091,"twenty":-4.967679,"median":-0.398908,"eighty":-0.235241,"marketCap":6813072},{"date":"2026-01-02","current":-0.230813,"twenty":-4.960352,"median":-0.396262,"eighty":-0.234801,"marketCap":6262850},{"date":"2026-01-09","current":-0.267986,"twenty":-4.960352,"median":-0.395503,"eighty":-0.235024,"marketCap":7271508},{"date":"2026-01-16","current":-0.2984,"twenty":-4.925606,"median":-0.392535,"eighty":-0.235219,"marketCap":8096774},{"date":"2026-01-23","current":-0.314959,"twenty":-4.86998,"median":-0.391393,"eighty":-0.235238,"marketCap":8546085},{"date":"2026-01-30","current":-0.354076,"twenty":-4.841932,"median":-0.390649,"eighty":-0.235277,"marketCap":9607469},{"date":"2026-02-06","current":-0.336926,"twenty":-4.782328,"median":-0.389903,"eighty":-0.23551,"marketCap":9142111},{"date":"2026-02-13","current":-0.333884,"twenty":-4.76765,"median":-0.389142,"eighty":-0.235899,"marketCap":9059584},{"date":"2026-02-20","current":-0.350781,"twenty":-4.76504,"median":-0.388794,"eighty":-0.235903,"marketCap":9518065},{"date":"2026-02-27","current":-0.343684,"twenty":-4.740785,"median":-0.38547,"eighty":-0.236196,"marketCap":9325503},{"date":"2026-03-06","current":-0.315297,"twenty":-4.653708,"median":-0.38427,"eighty":-0.236277,"marketCap":8555255},{"date":"2026-03-13","current":-0.331181,"twenty":-4.609175,"median":-0.383567,"eighty":-0.236338,"marketCap":8986227},{"date":"2026-03-20","current":-0.314622,"twenty":-4.542375,"median":-0.383263,"eighty":-0.237417,"marketCap":8536916},{"date":"2026-03-27","current":-0.2886,"twenty":-4.475575,"median":-0.381152,"eighty":-0.237718,"marketCap":7830855},{"date":"2026-04-02","current":-0.293669,"twenty":-4.471122,"median":-0.379597,"eighty":-0.23791,"marketCap":7968399},{"date":"2026-04-10","current":-0.28894,"twenty":-4.456649,"median":-0.3794,"eighty":-0.238072,"marketCap":7840076},{"date":"2026-04-17","current":-0.230161,"twenty":-4.440562,"median":-0.378211,"eighty":-0.238072,"marketCap":7977621},{"date":"2026-04-24","current":-0.229367,"twenty":-4.300841,"median":-0.375938,"eighty":-0.236326,"marketCap":7950112},{"date":"2026-05-01","current":-0.211907,"twenty":-4.101497,"median":-0.374432,"eighty":-0.235379,"marketCap":7344913},{"date":"2026-05-08","current":-0.202383,"twenty":-3.972352,"median":-0.37178,"eighty":-0.234868,"marketCap":7014805},{"date":"2026-05-15","current":-0.186123,"twenty":-3.803126,"median":-0.369434,"eighty":-0.234714,"marketCap":6451220},{"date":"2026-05-22","current":-0.143979,"twenty":-3.513661,"median":-0.366392,"eighty":-0.233733,"marketCap":5811096},{"date":"2026-05-29","current":-0.124554,"twenty":-3.339982,"median":-0.365679,"eighty":-0.231934,"marketCap":5027097},{"date":"2026-06-05","current":-0.137504,"twenty":-3.331075,"median":-0.364787,"eighty":-0.231354,"marketCap":5549763},{"date":"2026-06-12","current":-0.133972,"twenty":-3.282089,"median":-0.364324,"eighty":-0.230493,"marketCap":5407218},{"date":"2026-06-18","current":-0.125967,"twenty":-3.190796,"median":-0.362868,"eighty":-0.229784,"marketCap":5084115},{"date":"2026-06-26","current":-0.107131,"twenty":-3.144036,"median":-0.362181,"eighty":-0.228724,"marketCap":4323874},{"date":"2026-07-02","current":-0.180121,"twenty":-3.126223,"median":-0.361158,"eighty":-0.227926,"marketCap":7269810},{"date":"2026-07-10","current":-0.225916,"twenty":-3.072783,"median":-0.359601,"eighty":-0.227692,"marketCap":9118147},{"date":"2026-07-17","current":-0.194719,"twenty":-3.02825,"median":-0.358247,"eighty":-0.22682,"marketCap":7858997},{"date":"2026-07-24","current":-0.170703,"twenty":-2.96145,"median":-0.355681,"eighty":-0.225399,"marketCap":6889689},{"date":"2026-07-31","current":-0.123612,"twenty":-2.899104,"median":-0.354076,"eighty":-0.224633,"marketCap":4989085},{"date":"2026-08-07","current":-0.100538,"twenty":-2.868822,"median":-0.352135,"eighty":-0.223319,"marketCap":4057789},{"date":"2026-08-14","current":-0.091265,"twenty":-2.810038,"median":-0.351289,"eighty":-0.221991,"marketCap":3683513},{"date":"2026-08-21","current":-0.073392,"twenty":-2.685345,"median":-0.348734,"eighty":-0.220957,"marketCap":3143688}],"updateTime":1787449777840},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RNAZ\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2637434434","title":"TransCode Therapeutics falls short of Nasdaq $2.5 million stockholders' equity requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2637434434","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637434434?lang=en_us&edition=fundamental","pubTime":"2026-05-23 04:17","pubTimestamp":1779481051,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics received a Nasdaq deficiency notice on May 19, 2026 for failing to meet the Nasdaq Capital Market’s minimum stockholders’ equity rule.Stockholders’ equity was $1,251,427 as of the quarter ended March 31, 2026, below the $2,500,000 required under Listing Rule 5550.The notice does not trigger an immediate delisting, but the company must submit a compliance plan by July 3, 2026.Nasdaq may grant up to a 180-day extension to regain compliance; failure to secure acceptance or regain compliance could lead to a delisting determination, subject to appeal.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transcode Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDL21KqrN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNAZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635559840","title":"TransCode Therapeutics Q1 EPS $(21.28) Up From $(70.16) YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2635559840","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635559840?lang=en_us&edition=fundamental","pubTime":"2026-05-16 06:43","pubTimestamp":1778884997,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics (NASDAQ:RNAZ) reported quarterly losses of $(21.28) per share. This is a 69.67 percent increase over losses of $(70.16) per share from the same period last year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52620544/transcode-therapeutics-q1-eps-21-28-up-from-70-16-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"TransCode Therapeutics Q1 EPS $(21.28) Up From $(70.16) YoY","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635377250","title":"TransCode Therapeutics Q1 FY26 net loss widens to $17.79 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635377250","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635377250?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:17","pubTimestamp":1778876258,"startTime":"0","endTime":"0","summary":"Transcode Therapeutics posted a net loss of USD 17.79 million for the three months ended March 31, 2026, widening from USD 12.09 million a year earlier.Operating loss widened to USD 17.76 million from USD 3.17 million, as total operating expenses climbed to USD 17.76 million from USD 3.17 million.Research and development expense rose to USD 5.11 million from USD 2.22 million, while acquired in-process research and development expense was USD 10.43 million.Cash totaled about USD 12.8 million at quarter-end; cash used in operating activities increased to USD 4.98 million from USD 3.1 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transcode Therapeutics Inc. published the original content used to generate this news brief via EDGA","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL1fY0ZQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNAZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634467230","title":"TransCode Therapeutics announces virtual special shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2634467230","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634467230?lang=en_us&edition=fundamental","pubTime":"2026-05-09 05:22","pubTimestamp":1778275328,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics will hold a virtual special stockholder meeting in 2026 to seek approval for potential issuances of common stock tied to several financing and strategic transactions.Vote will cover conversion of Series A Non-Voting Convertible Preferred Stock and Series B Non-Voting Convertible Preferred Stock into common stock, representing up to 14,658,055 shares on an as-converted basis.Stockholders will also vote on conversion of Series C Non-Voting Convertible Preferred Stock into common stock, representing up to 1,214,204 shares.Another proposal seeks authorization for potential issuance of common stock under standby equity purchase agreement with YA II PN, LTD and related Convertible Notes, beyond an existing 183,301-share cap.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDLST1vH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","RNAZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632484856","title":"TransCode Registers 1.53 Million Shares for YA II PN Resale Under Equity Purchase Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2632484856","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632484856?lang=en_us&edition=fundamental","pubTime":"2026-05-01 22:43","pubTimestamp":1777646608,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics  filed a resale registration Thursday covering up to 1.53 million shares that YA II PN Ltd may sell from time to time.YA II PN, also known as Yorkville, is the counterparty to the company's standby equity purchase agreement signed April 6, according to the preliminary prospectus filed with regulators.The shares include 750,000 issuable upon conversion of convertible notes, 750,000 that may be issued through advances under the agreement, and 33,334 commitment shares. TransCode said it has received $950,000 from the sale of a convertible note and may receive up to $18.8 million more from additional note sales and share issuances under the facility.TransCode will not receive proceeds from the selling stockholder's resale of the registered shares.Price: 8.40, Change: +0.39, Percent Change: +4.87","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","EQR","RNAZ","BK4139","BK4215","BK4585","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632629316","title":"Transcode Therapeutics files to sell 15.96M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2632629316","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632629316?lang=en_us&edition=fundamental","pubTime":"2026-05-01 05:30","pubTimestamp":1777584652,"startTime":"0","endTime":"0","summary":"17:27 EDT Transcode Therapeutics (RNAZ) files to sell 15.96M shares of common stock for holders Published first on TheFly – the ultimate source for...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/transcode-therapeutics-files-to-sell-15-96m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/transcode-therapeutics-files-to-sell-15-96m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","RNAZ","BK4139","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632664097","title":"Transcode Therapeutics - Files for Resale of up to About 16 Mln Common Shares by Selling Stockholders - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2632664097","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632664097?lang=en_us&edition=fundamental","pubTime":"2026-05-01 05:27","pubTimestamp":1777584439,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nFWN41D1SG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RNAZ","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630396609","title":"Transcode Therapeutics Appoints DR. Anna Moore as Chair of Scientific Advisory Board; Announces Sponsored Research Agreement With Michigan State University","url":"https://stock-news.laohu8.com/highlight/detail?id=2630396609","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630396609?lang=en_us&edition=fundamental","pubTime":"2026-04-27 20:02","pubTimestamp":1777291320,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUACZ9SH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RNAZ","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630396641","title":"Press Release: TransCode Therapeutics Appoints Dr. Anna Moore as Chair of Scientific Advisory Board; Announces Sponsored Research Agreement with Michigan State University","url":"https://stock-news.laohu8.com/highlight/detail?id=2630396641","media":"Dow Jones","labels":["executive","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630396641?lang=en_us&edition=fundamental","pubTime":"2026-04-27 20:02","pubTimestamp":1777291320,"startTime":"0","endTime":"0","summary":"BOSTON, April 27, 2026 /PRNewswire/ -- TransCode Therapeutics, Inc. , a clinical stage company pioneering RNA and immuno-oncology therapeutics for the treatment of high risk and advanced cancers, today announced the appointment of Anna Moore, PhD, as Chair of its Scientific Advisory Board and the signing of a sponsored research agreement  with Michigan State University .Dr. Moore has played a foundational role in the scientific development of TransCode's RNA platform and pipeline, including the advancement of its lead therapeutic candidate, TTX-MC138, an antagomiR targeting microRNA-10b. As Chair of the Scientific Advisory Board, she will provide strategic guidance on the company's research and development efforts, with a focus on advancing innovative RNA-based approaches for the treatment of advanced cancers.TransCode Therapeutics is a clinical stage company pioneering immuno-oncology and RNA therapeutic treatments for high risk and advanced cancers. The company's lead therapeutic can","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","BK4135","BK4539","BK4588","IE0034235188.USD","LU1894683264.USD","STT","IE00B64PRP62.GBP","LU1883839398.USD","BK4585","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU0061475181.USD","LU1894683348.USD","RNAZ","RNA","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628755279","title":"CK Life Sciences publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2628755279","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628755279?lang=en_us&edition=fundamental","pubTime":"2026-04-17 16:40","pubTimestamp":1776415218,"startTime":"0","endTime":"0","summary":"CK Life Sciences annual report for year ended Dec. 31, 2025 outlined a corporate reorganization to intensify pharmaceuticals and diagnostics R&D.TransCode Therapeutics acquired late-stage melanoma vaccine seviprotimut-L in Oct. 2025; CK Life Sciences invested USD 25 million in TransCode to support continued development.Dogwood Therapeutics advanced non-opioid pain candidate Halneuron in Phase 2b for chemotherapy-induced neuropathic pain; interim analysis showed higher responder rates versus placebo.New unit Sequencio Therapeutics consolidated in-house cancer vaccine R&D; preclinical TROP2 vaccine candidates delivered complete tumor growth inhibition in breast and colorectal cancer mouse studies.Commercial businesses faced tariff-driven cost pressure; nutraceutical segment revenue declined 2%, agriculture-related revenue fell 2%.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely info","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nNDL7fSy3c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DWTX","RNAZ","BK4139","BK1161","BK1569","BK4539","00775"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627308062","title":"TransCode Therapeutics FY25 net loss widens to $34.7 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2627308062","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627308062?lang=en_us&edition=fundamental","pubTime":"2026-04-16 04:19","pubTimestamp":1776284341,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics posted net loss of $34.7 million for fiscal 2025, widening from $16.8 million a year earlier.Operating loss widened to $28 million from $15.7 million, while revenue remained at no revenue.Research and development expense climbed to $13.4 million from $9.7 million, while general and administrative expense rose to $14.6 million from $6 million due to $8.8 million of acquisition-related transaction costs.TransCode ended 2025 with cash of $17.8 million and expects it to fund operations through about year-end 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transcode Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDLFXyLy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625951805","title":"Transcode Therapeutics signs flexible financing agreement for up to $20M","url":"https://stock-news.laohu8.com/highlight/detail?id=2625951805","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625951805?lang=en_us&edition=fundamental","pubTime":"2026-04-07 22:29","pubTimestamp":1775572164,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics (RNAZ) has entered into an agreement with an institutional healthcare investor for financing of up to $20M. The arrangement ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/transcode-therapeutics-signs-flexible-financing-agreement-for-up-to-20m-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/transcode-therapeutics-signs-flexible-financing-agreement-for-up-to-20m-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4539","BK4588","RNAZ","IXJ","BK4139","BK4007","VHT","BK4585","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625955663","title":"TransCode Therapeutics Secures New Financing to Extend Runway","url":"https://stock-news.laohu8.com/highlight/detail?id=2625955663","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625955663?lang=en_us&edition=fundamental","pubTime":"2026-04-07 21:06","pubTimestamp":1775567197,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics ( ($RNAZ) ) has issued an announcement. On April 6, 2026, TransCode Therapeutics entered into a financing arrangement with i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/transcode-therapeutics-secures-new-financing-to-extend-runway?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/transcode-therapeutics-secures-new-financing-to-extend-runway?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625655958","title":"Press Release: TransCode Therapeutics Enters into Agreements for up to $20 Million Flexible Financing, Extending Company's Runway into Late 2027/Early 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2625655958","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625655958?lang=en_us&edition=fundamental","pubTime":"2026-04-07 20:30","pubTimestamp":1775565000,"startTime":"0","endTime":"0","summary":"BOSTON, April 7, 2026 /PRNewswire/ -- TransCode Therapeutics, Inc. , a clinical stage company pioneering immuno-oncology and RNA for the treatment of high risk and advanced cancer, today announced that it has entered into an agreement with an institutional healthcare investor for financing of up to $20 million. The arrangement comprises pre-paid advances of up to $6 million and a three-year Standby Equity Purchase Agreement  providing the Company the right to sell up to $14 million of its common stock to the investor, subject to certain conditions.\"The financing agreement provides TransCode with financial flexibility and ensures that TransCode can maintain operational momentum as we conduct our Phase 2a trial for our lead clinical program, TTX-MC138,\" said Dr. Philippe P Calais, Pharm.D., Ph.D., Chairman and CEO of TransCode.  \"This runway extension should enable the Company to complete the Phase 2a study and subsequently explore a strategic collaboration for the program,\" said Tom Fit","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SEPA","RNAZ","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624563615","title":"TransCode Therapeutics Delays 2025 Annual Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2624563615","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624563615?lang=en_us&edition=fundamental","pubTime":"2026-04-01 10:25","pubTimestamp":1775010353,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics ( ($RNAZ) ) has released a notification of late filing. TransCode Therapeutics, Inc. has filed a Form 12b-25 to notify inves...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/transcode-therapeutics-delays-2025-annual-filing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/transcode-therapeutics-delays-2025-annual-filing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624303365","title":"TransCode Therapeutics delays annual report filing, cites complex accounting for transactions","url":"https://stock-news.laohu8.com/highlight/detail?id=2624303365","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624303365?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:20","pubTimestamp":1774988453,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics reported it will miss deadline for its fiscal year ended Dec. 31, 2025 Form 10-K filing.Delay was tied to added disclosures and complex accounting tied to transactions completed in October 2025.Company expects to file within SEC Rule 12b-25 extension period of 15 calendar days.Results are expected to show a significant change from prior-year period due to transactions, with accounting still being finalized.Transactions included a private placement involving about USD 25 million of Series B preferred stock.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transcode Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval syste","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL4TW6Q2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAZ","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616372971","title":"TransCode Therapeutics Issues 1.14M Non-Voting Convertible Preferred Shares in Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2616372971","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616372971?lang=en_us&edition=fundamental","pubTime":"2026-03-04 05:54","pubTimestamp":1772574894,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics Inc. said it entered into an exclusive, worldwide, fully paid-up royalty-free license agreement with Unleash Immuno Oncolytics and will make a one-time payment in stock. Unleash will receive 1,136,364 shares of a new series of non-voting convertible preferred stock, convertible into an equal number of TransCode common shares, representing about 6.8% of the company’s fully diluted common stock assuming conversion of all preferred stock outstanding.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transcode Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL9StNPg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAZ","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616740183","title":"TransCode Therapeutics Expands Pipeline With Oncolytic Virus Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2616740183","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616740183?lang=en_us&edition=fundamental","pubTime":"2026-03-04 05:37","pubTimestamp":1772573871,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics ( ($RNAZ) ) just unveiled an update. TransCode Therapeutics, Inc. is a Boston-based clinical-stage biotechnology company pio...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/transcode-therapeutics-expands-pipeline-with-oncolytic-virus-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/transcode-therapeutics-expands-pipeline-with-oncolytic-virus-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616328797","title":"Transcode Therapeutics enters exclusive license agreement with Unleash","url":"https://stock-news.laohu8.com/highlight/detail?id=2616328797","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616328797?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:13","pubTimestamp":1772543608,"startTime":"0","endTime":"0","summary":"TransCode Therapeutics (RNAZ) announced that it has entered into an exclusive, worldwide, fully paid-up royalty-free license agreement with Unleash...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/transcode-therapeutics-enters-exclusive-license-agreement-with-unleash-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/transcode-therapeutics-enters-exclusive-license-agreement-with-unleash-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","BK4007","LENZ","RNAZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616328931","title":"BRIEF-Transcode Therapeutics Inc - Enters Exclusive License Agreement With Unleash","url":"https://stock-news.laohu8.com/highlight/detail?id=2616328931","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616328931?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:12","pubTimestamp":1772543527,"startTime":"0","endTime":"0","summary":"BRIEF-Transcode Therapeutics Inc - Enters Exclusive License Agreement With UnleashMarch 3 (Reuters) - Transcode Therapeutics Inc RNAZ.O:TRANSCODE THERAPEUTICS INC - ENTERS EXCLUSIVE LICENSE AGREEMENT ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nFWN3ZR198:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","RNAZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":43,"code":"91000000","status":"200"}]}}